Aerosol Cyclosporine for Prevention of Lung Rejection
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the efficacy of aerosolized cyclosporine given in addition to the standard oral
immunosuppressive drug regimen, in preventing acute rejection immediately after lung
transplantation